Effectiveness of methadone versus buprenorphine in the treatment of opioid use disorder: secondary analyses of prospective cohort study data
Objectives To compare the effectiveness of buprenorphine-naloxone (bup/nal) and methadone maintenance therapy (MMT) in the treatment of patients with opioid use disorder (OUD) during the fentanyl era.Design Secondary analysis of prospective cohort study data.Setting Data for the study were collected...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-06-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/6/e095645.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850099441197907968 |
|---|---|
| author | Andrew Worster Lehana Thabane Zainab Samaan James Paul Tea Rosic Leen Naji Brittany Dennis |
| author_facet | Andrew Worster Lehana Thabane Zainab Samaan James Paul Tea Rosic Leen Naji Brittany Dennis |
| author_sort | Andrew Worster |
| collection | DOAJ |
| description | Objectives To compare the effectiveness of buprenorphine-naloxone (bup/nal) and methadone maintenance therapy (MMT) in the treatment of patients with opioid use disorder (OUD) during the fentanyl era.Design Secondary analysis of prospective cohort study data.Setting Data for the study were collected from 54 clinical sites across Ontario, Canada, between May 2018 and January 2023.Participants To be included in the present study, participants had to be at least 16 years of age, have provided written informed consent and be receiving either MMT or bup/nal therapy for OUD. This study includes data from 2601 participants, of whom 2068 were receiving MMT and 533 were receiving bup/nal for OUD. The mean age of participants was 39.4 years (SD: 10.9), and 45% were female.Interventions MMT or bup/nal treatment for OUD.Outcome measures We employed a propensity score matched analysis to compare treatment outcomes among patients receiving MMT compared with bup/nal. We used ongoing illicit opioid use as an indicator of treatment outcome. We considered participants with >50% of urine drug screens in the past 12 months positive for non-prescribed opioids to be ‘non-responders’. We conducted subgroup analyses to identify whether treatment type was associated with ongoing non-prescribed opioid use among patients with and without a history of intravenous drug use (IVDU), and whether treatment type was associated with retention in treatment.Results Eight per cent of patients on bup/nal were considered non-responders, compared with 11.9% of patients on MMT. We did not find a statistically significant association between treatment type and treatment response. However, we did find that patients on MMT were more likely to stay in treatment for 12 months (OR 1.79, 95% CI 1.45 to 2.22, p<0.001). We also found that, among patients without a history of IVDU, those on MMT were more likely to continue using non-prescribed opioids, compared with those on bup/nal (OR 1.72, 95% CI 1.07 to 2.77, p=0.023).Conclusions Among a cohort of patients with OUD receiving treatment during the fentanyl era, we find that there is no statistically significant difference in ongoing non-prescribed opioid use between patients receiving MMT compared with bup/nal. Future studies should aim to further compare treatment effectiveness using patient-centred outcomes and pragmatic trial designs. |
| format | Article |
| id | doaj-art-694d67afdfbe4223a858d9f464f51da1 |
| institution | DOAJ |
| issn | 2044-6055 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open |
| spelling | doaj-art-694d67afdfbe4223a858d9f464f51da12025-08-20T02:40:29ZengBMJ Publishing GroupBMJ Open2044-60552025-06-0115610.1136/bmjopen-2024-095645Effectiveness of methadone versus buprenorphine in the treatment of opioid use disorder: secondary analyses of prospective cohort study dataAndrew Worster0Lehana Thabane1Zainab Samaan2James Paul3Tea Rosic4Leen Naji5Brittany Dennis6Department of Medicine, McMaster University, Hamilton, Ontario, CanadaDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, CanadaDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, CanadaDepartment of Anesthesia, McMaster University, Hamilton, Ontario, CanadaDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, CanadaFamily, Community & Preventative Medicine, The University of Arizona College of Medicine Phoenix, Phoenix, Arizona, USAMedicine, British Columbia Centre on Substance Use, Vancouver, British Columbia, CanadaObjectives To compare the effectiveness of buprenorphine-naloxone (bup/nal) and methadone maintenance therapy (MMT) in the treatment of patients with opioid use disorder (OUD) during the fentanyl era.Design Secondary analysis of prospective cohort study data.Setting Data for the study were collected from 54 clinical sites across Ontario, Canada, between May 2018 and January 2023.Participants To be included in the present study, participants had to be at least 16 years of age, have provided written informed consent and be receiving either MMT or bup/nal therapy for OUD. This study includes data from 2601 participants, of whom 2068 were receiving MMT and 533 were receiving bup/nal for OUD. The mean age of participants was 39.4 years (SD: 10.9), and 45% were female.Interventions MMT or bup/nal treatment for OUD.Outcome measures We employed a propensity score matched analysis to compare treatment outcomes among patients receiving MMT compared with bup/nal. We used ongoing illicit opioid use as an indicator of treatment outcome. We considered participants with >50% of urine drug screens in the past 12 months positive for non-prescribed opioids to be ‘non-responders’. We conducted subgroup analyses to identify whether treatment type was associated with ongoing non-prescribed opioid use among patients with and without a history of intravenous drug use (IVDU), and whether treatment type was associated with retention in treatment.Results Eight per cent of patients on bup/nal were considered non-responders, compared with 11.9% of patients on MMT. We did not find a statistically significant association between treatment type and treatment response. However, we did find that patients on MMT were more likely to stay in treatment for 12 months (OR 1.79, 95% CI 1.45 to 2.22, p<0.001). We also found that, among patients without a history of IVDU, those on MMT were more likely to continue using non-prescribed opioids, compared with those on bup/nal (OR 1.72, 95% CI 1.07 to 2.77, p=0.023).Conclusions Among a cohort of patients with OUD receiving treatment during the fentanyl era, we find that there is no statistically significant difference in ongoing non-prescribed opioid use between patients receiving MMT compared with bup/nal. Future studies should aim to further compare treatment effectiveness using patient-centred outcomes and pragmatic trial designs.https://bmjopen.bmj.com/content/15/6/e095645.full |
| spellingShingle | Andrew Worster Lehana Thabane Zainab Samaan James Paul Tea Rosic Leen Naji Brittany Dennis Effectiveness of methadone versus buprenorphine in the treatment of opioid use disorder: secondary analyses of prospective cohort study data BMJ Open |
| title | Effectiveness of methadone versus buprenorphine in the treatment of opioid use disorder: secondary analyses of prospective cohort study data |
| title_full | Effectiveness of methadone versus buprenorphine in the treatment of opioid use disorder: secondary analyses of prospective cohort study data |
| title_fullStr | Effectiveness of methadone versus buprenorphine in the treatment of opioid use disorder: secondary analyses of prospective cohort study data |
| title_full_unstemmed | Effectiveness of methadone versus buprenorphine in the treatment of opioid use disorder: secondary analyses of prospective cohort study data |
| title_short | Effectiveness of methadone versus buprenorphine in the treatment of opioid use disorder: secondary analyses of prospective cohort study data |
| title_sort | effectiveness of methadone versus buprenorphine in the treatment of opioid use disorder secondary analyses of prospective cohort study data |
| url | https://bmjopen.bmj.com/content/15/6/e095645.full |
| work_keys_str_mv | AT andrewworster effectivenessofmethadoneversusbuprenorphineinthetreatmentofopioidusedisordersecondaryanalysesofprospectivecohortstudydata AT lehanathabane effectivenessofmethadoneversusbuprenorphineinthetreatmentofopioidusedisordersecondaryanalysesofprospectivecohortstudydata AT zainabsamaan effectivenessofmethadoneversusbuprenorphineinthetreatmentofopioidusedisordersecondaryanalysesofprospectivecohortstudydata AT jamespaul effectivenessofmethadoneversusbuprenorphineinthetreatmentofopioidusedisordersecondaryanalysesofprospectivecohortstudydata AT tearosic effectivenessofmethadoneversusbuprenorphineinthetreatmentofopioidusedisordersecondaryanalysesofprospectivecohortstudydata AT leennaji effectivenessofmethadoneversusbuprenorphineinthetreatmentofopioidusedisordersecondaryanalysesofprospectivecohortstudydata AT brittanydennis effectivenessofmethadoneversusbuprenorphineinthetreatmentofopioidusedisordersecondaryanalysesofprospectivecohortstudydata |